Governance & Councils

Members of the Board


  • Mr. Andrew TOPEN, Head of Public Affairs Europe & Global Business Franchises, representing Novartis


  • Dr. Peter HEINRICH, Chair of the EuropaBio SME Platform; representing BIO Deutschland e.V.
  • Mr Matthew MORAN, Chair of the EuropaBio National Associations Council; Head of the Irish Biotech Association, representing BioPharmaChem Ireland
  • Mr. Neil MULCOCK, Chair of the EuropaBio Healthcare Biotechnology Council; Vice President Government Affairs and Policy EMEA, representing Gilead  
  • Dr. Marcus REMMERS, Chair of the EuropaBio Industrial Biotechnology Council, Chief Technology Officer, representing Royal DSM NV.


  • Dr. Carsten SIEDEN, Senior Vice President White Biotechnology Research, representing BASF

Regular Members

  • Mr. Ion AROCENA VELEZ, General Manager, representing the Spanish Bioindustry Association (ASEBIO)
  • Mr. Steve BATES, Chief Executive Officer, representing the BioIndustry Association (BIA)
  • Prof. Dr. Stefan BUCHHOLZ, Head of Research & Development for the Division Nutrition & Care, representing Evonik Operations GmbH
  • Mr. David EARNSHAW, Associate Vice President for Public Policy Europe & Canada, representing MSD Europe Inc.
  • Mr. Claus Crone FUGLSANG, CSO, SVP Research and Technology, representing Novozymes A/S
  • Dr. Ricardo GENT, Executive Director of the German Association of Biotechnology Industries (DIB)
  • Mr. Peter KURTZHALS, Senior Vice President and Chief Scientific Advisor, representing Novo Nordisk A/S
  • Mr. Marcel LECHANTEUR, President and General Manager Lilly France, Benelux, North West Africa and European Affairs, representing Lilly
  • Dr. Maria Luisa NOLLI, representing Assobiotec
  • Prof. Dr. Arjen VAN TUNEN, CEO, representing Keygene
  • Mrs. Annemiek VERKAMMAN, Managing Director, representing HollandBIO 
  • Dr. Marcel WUBBOLTS, Chief Science & Sustainability Officer, representing Corbion.

Director General Ad-Interim

  • Bernard GRIMM